BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 32845598)

  • 1. Cutaneous Langerhans Cell Histiocytosis Responsive to Topical Nitrogen Mustard.
    Bui AN; Puleo AE; Canales AL; Jacobsen ED; LeBoeuf NR
    J Drugs Dermatol; 2020 Aug; 19(8):803-805. PubMed ID: 32845598
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Topical nitrogen mustard therapy in patients with Langerhans cell histiocytosis.
    Lindahl LM; Fenger-Grøn M; Iversen L
    Br J Dermatol; 2012 Mar; 166(3):642-5. PubMed ID: 21967132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long term follow up of topical mustine treatment for cutaneous langerhans cell histiocytosis.
    Hoeger PH; Nanduri VR; Harper JI; Atherton DA; Pritchard J
    Arch Dis Child; 2000 Jun; 82(6):483-7. PubMed ID: 10833183
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Topical therapy using nitrogen mustard (chlormethine hydrochlorate) for cutaneous manifestations of histiocytosis X (author's transl)].
    Lemarchand-Venencie F; Saurat JH
    Ann Pediatr (Paris); 1982 Jan; 29(1):70-3. PubMed ID: 6976769
    [No Abstract]   [Full Text] [Related]  

  • 5. Topical nitrogen mustard ointment with occlusion for Langerhans' cell histiocytosis of the scalp.
    Treat JR; Suchin KR; James WD
    J Dermatolog Treat; 2003 Jan; 14(1):46-7. PubMed ID: 12745855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Topical nitrogen mustard: an effective treatment for cutaneous Langerhans cell histiocytosis.
    Sheehan MP; Atherton DJ; Broadbent V; Pritchard J
    J Pediatr; 1991 Aug; 119(2):317-21. PubMed ID: 1861222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cutaneous Langerhans cell histiocytosis - an indication for dermatological pharmacotherapy with topical nitrogen mustard.
    Schlinsog AS; Kreft B; Marsch WC
    J Dtsch Dermatol Ges; 2018 Sep; 16(9):1133-1135. PubMed ID: 30112832
    [No Abstract]   [Full Text] [Related]  

  • 8. Langerhans cell histiocytosis: an uncommon presentation, successfully treated by thalidomide.
    Shahidi-Dadras M; Saeedi M; Shakoei S; Ayatollahi A
    Indian J Dermatol Venereol Leprol; 2011; 77(5):587-90. PubMed ID: 21860158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histiocytosis X in two adults. Treatment with topical mechlorethamine.
    Nethercott JR; Murray AH; Medwidsky W; Chalvardjian A
    Arch Dermatol; 1983 Feb; 119(2):157-61. PubMed ID: 6600596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Isolated cutaneous Langerhans histiocytosis. Clinical and immunohistologic improvement after local application of nitrogen mustard].
    Thivolet J; Cambazard F; Euvrard S; Hermier M; Kanitakis J
    Ann Dermatol Venereol; 1984; 111(8):765-6. PubMed ID: 6397098
    [No Abstract]   [Full Text] [Related]  

  • 11. Histiocytosis X: treatment with topical nitrogen mustard.
    Berman B; Chang DL; Shupack JL
    J Am Acad Dermatol; 1980 Jul; 3(1):23-9. PubMed ID: 6967494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful treatment of cutaneous langerhans cell histiocytosis with thalidomide.
    Sander CS; Kaatz M; Elsner P
    Dermatology; 2004; 208(2):149-52. PubMed ID: 15057007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histiocytosis X in two infants--treated with topical nitrogen mustard.
    Zachariae H
    Br J Dermatol; 1979 Apr; 100(4):433-8. PubMed ID: 313216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Widespread skin-limited adult Langerhans cell histiocytosis: long-term follow-up with good response to interferon alpha.
    Chang SE; Koh GJ; Choi JH; Lee KH; Sung KJ; Moon KC; Koh JK
    Clin Exp Dermatol; 2002 Mar; 27(2):135-7. PubMed ID: 11952707
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Langerhans cell histiocytosis in the elderly].
    Gerlach B; Stein A; Fischer R; Wozel G; Dittert DD; Richter G
    Hautarzt; 1998 Jan; 49(1):23-30. PubMed ID: 9522189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adult-onset systemic Langerhans cell histiocytosis mimicking inflammatory bowel disease: the value of skin biopsy and review of cases of Langerhans cell histiocytosis with cutaneous involvement seen at the Mayo Clinic.
    Podjasek JO; Loftus CG; Smyrk TC; Wieland CN
    Int J Dermatol; 2014 Mar; 53(3):305-11. PubMed ID: 23621577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A prospective study of cutaneous intolerance to topical mechlorethamine therapy in patients with cutaneous T-cell lymphomas. French Study Group of Cutaneous Lymphomas.
    Estève E; Bagot M; Joly P; Souteyrand P; Beylot-Barry M; Vaillant L; Delaunay M; Avril MF; Laroche L; Grange F; Thomine E; Wechsler J
    Arch Dermatol; 1999 Nov; 135(11):1349-53. PubMed ID: 10566833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment of Langerhans-cell histiocytosis by oral cyclosporin A and topical nitrogen mustard].
    Forssman T; Fluhr J; Djawari D; Gloor M; Rumpelt HJ
    Ann Dermatol Venereol; 1994; 121(10):734. PubMed ID: 7793767
    [No Abstract]   [Full Text] [Related]  

  • 19. An unusual case of adult disseminated cutaneous Langerhans cell histiocytosis.
    Moravvej H; Yousefi M; Barikbin B
    Dermatol Online J; 2006 Oct; 12(6):13. PubMed ID: 17083893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histiocytosis X of the scalp and face responding to topical nitrogen mustard.
    Monk BE; McKee PH; du Vivier A
    J R Soc Med; 1985; 78 Suppl 11(Suppl 11):6-7. PubMed ID: 3879287
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.